Format
Sort by
Items per page

Send to

Choose Destination

Best matches for ULIPRISTAL/PD:

Search results

Items: 1 to 20 of 257

1.

Choice of contraceptives.

[No authors listed]

Med Lett Drugs Ther. 2018 Oct 8;60(1557):161-168. No abstract available.

PMID:
30335731
2.

Ulipristal acetate induces cell cycle delay and remodeling of extracellular matrix.

Shin SJ, Kim J, Lee S, Baek J, Lee JE, Cho C, Ha E.

Int J Mol Med. 2018 Oct;42(4):1857-1864. doi: 10.3892/ijmm.2018.3779. Epub 2018 Jul 17.

3.

Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids.

Tuschy B, Gabbert M, Weiss C, Hornemann A, Wuhrer A, Sütterlin M, Berlit S.

Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:106-110. doi: 10.1016/j.ejogrb.2018.06.027. Epub 2018 Jun 17.

PMID:
29920429
4.
5.

Gene expression changes in uterine myomas in response to ulipristal acetate treatment.

Courtoy GE, Donnez J, Ambroise J, Arriagada P, Luyckx M, Marbaix E, Dolmans MM.

Reprod Biomed Online. 2018 Aug;37(2):224-233. doi: 10.1016/j.rbmo.2018.04.050. Epub 2018 May 7.

PMID:
29807764
6.

Vilaprisan for treating uterine fibroids.

Melis GB, Neri M, Piras B, Paoletti AM, Ajossa S, Pilloni M, Marotto MF, Corda V, Saba A, Giancane E, Mais V.

Expert Opin Investig Drugs. 2018 May;27(5):497-505. doi: 10.1080/13543784.2018.1471134. Epub 2018 May 7. Review.

PMID:
29718788
7.

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.

Liang B, Wu L, Xu H, Cheung CW, Fung WY, Wong SW, Wang CC.

Reprod Biol Endocrinol. 2018 Apr 3;16(1):32. doi: 10.1186/s12958-018-0347-9.

8.

Predictive factor for volume reduction of uterine fibroids after short-term use of ulipristal acetate.

Yun BS, Seong SJ, Jung YW, Kim ML, Bae HS, Kim MK, Shim SS.

Eur J Obstet Gynecol Reprod Biol. 2018 May;224:133-136. doi: 10.1016/j.ejogrb.2018.03.026. Epub 2018 Mar 17.

PMID:
29602142
9.

Two synthetic progestins and natural progesterone are responsible for most of the progestagenic activities in municipal wastewater treatment plant effluents in the Czech and Slovak republics.

Šauer P, Stará A, Golovko O, Valentová O, Bořík A, Grabic R, Kroupová HK.

Water Res. 2018 Jun 15;137:64-71. doi: 10.1016/j.watres.2018.02.065. Epub 2018 Mar 2.

PMID:
29544204
10.

Ulipristal acetate for uterine fibroids: 2 years of real world experience in a UK hospital.

Woodhead N, Pounds R, Irani S, Pradhan P.

J Obstet Gynaecol. 2018 Aug;38(6):813-817. doi: 10.1080/01443615.2017.1405926. Epub 2018 Mar 12.

PMID:
29526144
11.

Emerging treatment options for uterine fibroids.

Donnez J, Arriagada P, Donnez O, Dolmans MM.

Expert Opin Emerg Drugs. 2018 Mar;23(1):17-23. doi: 10.1080/14728214.2018.1446943. Epub 2018 Mar 12. Review.

PMID:
29486606
12.

Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.

Badiani B, Chiumente M, Messori A.

Eur J Obstet Gynecol Reprod Biol. 2018 Mar;222:84-88. doi: 10.1016/j.ejogrb.2018.01.020. Epub 2018 Feb 3.

PMID:
29408752
13.

Non-surgical intervention for retroperitoneal lymphogenic and pulmonary metastases of a benign leiomyoma: treatment with ulipristal acetate.

Kortekaas KE, Pelikan HMP.

BMJ Case Rep. 2018 Jan 3;2018. pii: bcr-2017-222693. doi: 10.1136/bcr-2017-222693.

PMID:
29298791
14.

Pharmacokinetic drug evaluation of ulipristal acetate for the treatment of uterine fibroids.

Ferrero S, Vellone VG, Barra F.

Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):107-116. doi: 10.1080/17425255.2018.1417389. Epub 2017 Dec 20. Review.

PMID:
29250979
15.

Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.

Kannan A, Bhurke A, Sitruk-Ware R, Lalitkumar PG, Gemzell-Danielsson K, Williams ARW, Taylor RN, Bagchi MK, Bagchi IC.

Reprod Sci. 2018 Mar;25(3):320-328. doi: 10.1177/1933719117746764. Epub 2017 Dec 14.

PMID:
29241443
16.

Fibromes utérins. L'ulipristal approuvé pour une utilisation prolongée.

Couillard K.

Perspect Infirm. 2017 Mar-Apr;14(2):57. French. No abstract available.

PMID:
29236373
17.

Preoperative medical therapy before surgery for uterine fibroids.

Lethaby A, Puscasiu L, Vollenhoven B.

Cochrane Database Syst Rev. 2017 Nov 15;11:CD000547. doi: 10.1002/14651858.CD000547.pub2. Review.

PMID:
29139105
18.

Effect of ulipristal acetate and mifepristone at emergency contraception dose on the embryo-endometrial attachment using an in vitro human trophoblastic spheroid and endometrial cell co-culture model.

Li HWR, Li YX, Li TT, Fan H, Ng EH, Yeung WS, Ho PC, Lee KF.

Hum Reprod. 2017 Dec 1;32(12):2414-2422. doi: 10.1093/humrep/dex328.

PMID:
29121217
19.

Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis.

de Milliano I, Twisk M, Ket JC, Huirne JA, Hehenkamp WJ.

PLoS One. 2017 Oct 16;12(10):e0186158. doi: 10.1371/journal.pone.0186158. eCollection 2017. Review.

20.

Ulipristal Acetate and Extracellular Matrix Production in Human Leiomyomas In Vivo: A Laboratory Analysis of a Randomized Placebo Controlled Trial.

Cox J, Malik M, Britten J, Lewis T, Catherino WH.

Reprod Sci. 2018 Feb;25(2):198-206. doi: 10.1177/1933719117728802. Epub 2017 Sep 20.

PMID:
28929861

Supplemental Content

Loading ...
Support Center